Summit Therapeutics Inc. Contracts & Agreements
20 Contracts & Agreements
- Business Finance (15 contracts)
- Human Resources (2)
- Real Estate (1)
- Uncategorized (2)
- Amended and Restated Promissory Note, dated February 17, 2024, by and (Filed With SEC on February 20, 2024)
- Securities Purchase Agreement, dated October 13, 2023, by and between Summit Therapeutics, Inc. and Manmeet Soni (Filed With SEC on November 7, 2023)
- Employment Agreement, dated October 13, 2023, by and between Summit Therapeutics, Inc. and Manmeet Soni (Filed With SEC on November 7, 2023)
- Form of Subscription Rights Certificate (Filed With SEC on July 18, 2022)
- Promissory Note, dated March 10, 2022, issued by Summit Therapeutics Inc. in the name of Robert W. Duggan (Filed With SEC on March 11, 2022)
- Note Purchase Agreement, dated March 10, 2022, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on March 11, 2022)
- Exit Agreement, by and between Summit Therapeutics Inc. and Michael Donaldson, dated May 28, 2021 (Filed With SEC on May 28, 2021)
- Note Purchase Agreement, dated April 20, 2021, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on April 21, 2021)
- Rescission Agreement, dated April 20, 2021, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on April 21, 2021)
- Promissory Note, dated April 20, 2021, issued by Summit Therapeutics Inc. in the name of Robert W. Duggan (Filed With SEC on April 21, 2021)
- Form of Subscription Rights Certificate (Filed With SEC on April 21, 2021)
- Sublease Agreement (Filed With SEC on March 31, 2021)
- Contract of Employment (Filed With SEC on March 31, 2021)
- Promissory Note, dated March 24, 2021, issued by Summit Therapeutics Inc. in the name of Robert W. Duggan (Filed With SEC on March 26, 2021)
- Note Purchase Agreement, dated March 24, 2021, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on March 26, 2021)
- Securities Purchase Agreement, dated October 2, 2020, by and between Summit Therapeutics Inc. and Robert W. Duggan (incorporated by reference to Exhibit 10.1 to the Companys... (Filed With SEC on November 6, 2020)
- Registration Rights Agreement, dated November 6, 2020, by and between Summit Therapeutics Inc., Polar Capital Funds plc Biotechnology Fund and Mahkam Zanganeh Revocable Trust (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated November 6, 2020, by and between Summit Therapeutics Inc. and Mahkam Zanganeh Revocable Trust (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated November 6, 2020, by and between Summit Therapeutics Inc. and Polar Capital Funds plc Biotechnology Fund (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated October 2, 2020, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on October 5, 2020)